Verdiesen, Renée M GOnland-Moret, N Charlottevan Gils, Carla HStellato, Rebecca KSpijkerman, Annemieke M WPicavet, H Susan JBroekmans, Frank J MVerschuren, W M Moniquevan der Schouw, Yvonne T2020-11-042020-11-042020-10-131432-04283304817110.1007/s00125-020-05302-5http://hdl.handle.net/10029/624461During a median follow-up of 20 years, 163 women developed type 2 diabetes. Lower baseline age-specific AMH levels were associated with a higher type 2 diabetes risk (HRT2vsT3 1.24 [95% CI 0.81, 1.92]; HRT1vsT3 1.62 [95% CI 1.06, 2.48]; ptrend = 0.02). These findings seem to be supported by predicted AMH trajectories, which suggested that plasma AMH levels were lower at younger ages in women who developed type 2 diabetes compared with women who did not. The trajectories also suggested that AMH levels declined at a slower rate in women who developed type 2 diabetes, although differences in trajectories were not statistically significant.enAMHAnti-Müllerian hormoneLongitudinalReproductive ageingTrajectoriesType 2 diabetesWomenArticleDiabetologia 2020; advance online publication (ahead of print)